LE Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Completed · Phase 3

Conditions studied: Cataract, Pain, Ocular Inflammation

In brief

Loteprednol Etabonate Ophthalmic Gel, (BID and TID) versus Vehicle Group for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery.

Key facts

Study ID

NCT02786901

Run by

Bausch & Lomb Incorporated

People needed

600

Starts

2016-06-01

Expected to finish

2017-07-01

Last updated by the study team

2021-01-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Valeant Site 01 — Phoenix, Arizona, United States
• Valeant Site 03 — Oceanside, California, United States
• Valeant Site 05 — Miami, Florida, United States
• Valeant Site 04 — Quincy, Massachusetts, United States
• Valeant Site 06 — Kansas City, Missouri, United States
• Valeant Site 02 — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.